Davis T - Search Results

1

Cycling Werner's syndrome fibroblasts display calcium-dependent potassium currents.

Faragher RG, Hardy SP, Davis T, Dropcova S, Allen MC. Faragher RG, et al. Among authors: davis t. Exp Cell Res. 1997 Feb 25;231(1):119-22. doi: 10.1006/excr.1996.3437. Exp Cell Res. 1997. PMID: 9056418

2

Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.

Davis T, Singhrao SK, Wyllie FS, Haughton MF, Smith PJ, Wiltshire M, Wynford-Thomas D, Jones CJ, Faragher RG, Kipling D. Davis T, et al. J Cell Sci. 2003 Apr 1;116(Pt 7):1349-57. doi: 10.1242/jcs.00331. J Cell Sci. 2003. PMID: 12615976 Free article.

3

Investigation of the signaling pathways involved in the proliferative life span barriers in werner syndrome fibroblasts.

Davis T, Faragher RG, Jones CJ, Kipling D. Davis T, et al. Ann N Y Acad Sci. 2004 Jun;1019:274-7. doi: 10.1196/annals.1297.046. Ann N Y Acad Sci. 2004. PMID: 15247028

4

Replicative senescence in sheep fibroblasts is a p53 dependent process.

Davis T, Skinner JW, Faragher RG, Jones CJ, Kipling D. Davis T, et al. Exp Gerontol. 2005 Jan-Feb;40(1-2):17-26. doi: 10.1016/j.exger.2004.09.004. Exp Gerontol. 2005. PMID: 15664728

5

Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.

Alimbetov D, Davis T, Brook AJ, Cox LS, Faragher RG, Nurgozhin T, Zhumadilov Z, Kipling D. Alimbetov D, et al. Among authors: davis t. Biogerontology. 2016 Apr;17(2):305-15. doi: 10.1007/s10522-015-9610-z. Epub 2015 Sep 23. Biogerontology. 2016. PMID: 26400758 Free PMC article.

6

Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts.

Faragher RG, Burton DG, Majecha P, Fong NS, Davis T, Sheerin A, Ostler EL. Faragher RG, et al. Among authors: davis t. Age (Dordr). 2011 Dec;33(4):555-64. doi: 10.1007/s11357-010-9201-5. Epub 2011 Feb 12. Age (Dordr). 2011. PMID: 21318333 Free PMC article.

7

What can progeroid syndromes tell us about human aging?

Kipling D, Davis T, Ostler EL, Faragher RG. Kipling D, et al. Among authors: davis t. Science. 2004 Sep 3;305(5689):1426-31. doi: 10.1126/science.1102587. Science. 2004. PMID: 15353794 Review.

8

Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts.

Davis T, Bachler MA, Wyllie FS, Bagley MC, Kipling D. Davis T, et al. Ann N Y Acad Sci. 2010 Jun;1197:45-8. doi: 10.1111/j.1749-6632.2010.05195.x. Ann N Y Acad Sci. 2010. PMID: 20536832 Review.

9

Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor.

Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D. Davis T, et al. J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1386-93. doi: 10.1093/gerona/60.11.1386. J Gerontol A Biol Sci Med Sci. 2005. PMID: 16339323

10

Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome?

Davis T, Kipling D. Davis T, et al. Rejuvenation Res. 2006 Fall;9(3):402-7. doi: 10.1089/rej.2006.9.402. Rejuvenation Res. 2006. PMID: 16859481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,560 results

Search Page

Filters